US 9211419
Treatments of disease or disorders using nanoparticles for focused hyperthermia to increase therapy efficacy
granted A61KA61K41/0052A61K47/60
Quick answer
US patent 9211419 (Treatments of disease or disorders using nanoparticles for focused hyperthermia to increase therapy efficacy) held by The Board of Regents of the University of Texas System expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K41/0052, A61K47/60, A61P, A61P35/00